First-in-human trial of tocilizumab in combination with a standard induction chemotherapy in newly diagnosed acute myeloid leukemia patients: The phase 1 TOCILAM study.

被引：0
|
作者：
Peterlin, Pierre
Garnier, Alice
Le Bourgeois, Amandine
Guillaume, Thierry
Jullien, Maxime
Planche, Lucie
Gaschet, Joelle
Chevallier, Patrice
机构：
[1] CHU Nantes, Serv Hematol Clin, Nantes, France
[2] CHU Nantes, Hotel Dieu HME, Nantes, France
[3] Dept Hosp Ctr, Clin Res Ctr, La Roche Sur Yon, France
[4] Univ Angers, Nantes Univ, CNRS, Inserm,CRCI2NA, Nantes, France
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7028
引用
收藏
页数：1
相关论文
共 50 条
  • [31] A Phase 2 Randomized Study Comparing Venetoclax and Azacitidine to Conventional Induction Chemotherapy for Newly Diagnosed Fit Adults with Acute Myeloid Leukemia
    Fathi, Amir T.
    Fell, Geoffrey G.
    El-Jawahri, Areej
    Perl, Alexander E.
    Jonas, Brian A.
    Dias, Ajoy L.
    Mims, Alice S.
    Borate, Uma
    Ragon, Brittany Knick
    Grunwald, Michael R.
    Peters, Mary Linton B.
    Graubert, Timothy A.
    Amrein, Philip C.
    Hock, Hanno R.
    Brunner, Andrew M.
    Hobbs, Gabriela S.
    Narayan, Rupa
    Neuberg, Donna S.
    Aldoss, Ibrahim
    BLOOD, 2022, 140 : 3284 - 3286
  • [32] Gemtuzumab ozogamicin plus standard induction chemotherapy improves outcomes of newly diagnosed intermediate cytogenetic risk acute myeloid leukemia
    Hassan Awada
    Mina Abdelmalek
    Tara Cronin
    Jeffrey Baron
    Zakariya Kashour
    Farhan Azad
    Muhammad Salman Faisal
    Mark Faber
    Matthew Gravina
    Pamela J. Sung
    Steven D. Green
    Amanda Przespolewski
    James E. Thompson
    Elizabeth A. Griffiths
    Eunice S. Wang
    Blood Cancer Journal, 13
  • [33] Phase I trial of plerixafor combined with decitabine in newly diagnosed older patients with acute myeloid leukemia
    Roboz, Gail J.
    Ritchie, Ellen K.
    Dault, Yulia
    Lam, Linda
    Marshall, Danielle C.
    Cruz, Nicole M.
    Hsu, Hsiao-Ting C.
    Hassane, Duane C.
    Christos, Paul J.
    Ippoliti, Cindy
    Scandura, Joseph M.
    Guzman, Monica L.
    HAEMATOLOGICA, 2018, 103 (08) : 1308 - 1316
  • [34] Efficacy of Compound Kushen Injection in Combination with Induction Chemotherapy for Treating Adult Patients Newly Diagnosed with Acute Leukemia
    Tu, Honglei
    Lei, Bo
    Meng, Shan
    Liu, Hailing
    Wei, Yongchang
    He, Aili
    Zhang, Wanggang
    Zhou, Fuling
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2016, 2016
  • [35] INDOXIMOD IN COMBINATION WITH IDARUBICIN AND CYTARABINE FOR UPFRONT TREATMENT OF PATIENTS WITH NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA (AML): PHASE 1 REPORT
    Emadi, A.
    Holtzman, N. G.
    Imran, M.
    El Chaer, F.
    Koka, M.
    Singh, Z.
    Shahlaee, A.
    Sausville, E. A.
    Law, J.
    Lee, S. T.
    Banerjee, A.
    Rapoport, A.
    Baer, M. R.
    Duong, V. H.
    Munn, D. H.
    Loken, M.
    Kennedy, E.
    Vahanian, N.
    Link, C.
    HAEMATOLOGICA, 2017, 102 : 375 - 375
  • [36] A Phase I Study of Selinexor in Combination with Daunorubicin and Cytarabine in Patients with Newly Diagnosed Poor-Risk Acute Myeloid Leukemia
    Sweet, Kendra L.
    Komrokji, Rami S.
    Padron, Eric
    Cubitt, Christopher L.
    Khavarian, Leyla
    List, Alan F.
    Sallman, David
    Sullivan, Daniel
    Chavez, Julio C.
    Shah, Bijal D.
    Lancet, Jeffrey E.
    BLOOD, 2016, 128 (22)
  • [37] Phase 2 study of chidamide in combination with CAG and venetoclax-azacitidine in older patients with newly diagnosed acute myeloid leukemia
    Liu, Qingyang
    Yang, Jingjing
    Lv, Lei
    Zhang, Xiawei
    Li, Meng
    Xu, Lingmin
    Huang, Sai
    Jing, Yu
    Dou, Liping
    FRONTIERS IN IMMUNOLOGY, 2025, 16
  • [38] Phase 2 Study of the Combination of Cytarabine, Idarubicin , acid Niyolumab for Initial Therapy of Patients With Newly Diagnosed Acute Myeloid Leukemia
    不详
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2018, 16 (03) : 7 - 9
  • [39] A Phase 1b Study of Vadastuximab Talirine (33A) in Combination with 7+3 Induction Therapy for Patients with Newly Diagnosed Acute Myeloid Leukemia (AML)
    Walter, R.
    Erba, H.
    Ravandi, F.
    ANNALS OF HEMATOLOGY, 2017, 96 : S69 - S69
  • [40] Phase 2 Study of CPX-351 in Combination with Venetoclax in Patients with Newly Diagnosed, High Risk Acute Myeloid Leukemia
    Jen, Wei-Ying
    DiNardo, Courtney D.
    Chien, Kelly S.
    Alvarado-Valero, Yesid
    Masarova, Lucia
    Brandt, Mark
    Bull-Linderman, Debra
    Daver, Naval
    Montalban-Bravo, Guillermo
    Bataller, Alex
    Garcia-Manero, Guillermo
    Issa, Ghayas C.
    Alousi, Amin
    Short, Nicholas J.
    Ravandi, Farhad
    Kadia, Tapan M.
    BLOOD, 2023, 142
12345